OTC · LVRLF
CordovaCann Corp.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
Loading market information…
OTC · KHRNF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Khiron Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Khiron Life Sciences Corp.’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of -$0.02. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Khiron Life Sciences Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical Cannabis Products, and Wellbeing Products. A core focus for Khiron involves the end-to-end process of medical cannabis, encompassing the cultivation, manufacturing, distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) varieties. Additionally, the company manages a network of health centers and satellite clinics, notably under the ILANS and Zerenia brands. It also develops CBD-based cosmeceutical items, specifically marketed under its Kuida brand. Its healthcare footprint includes running Zerenia clinics in key locations such as Medellin and Peru. Khiron Life Sciences Corp. was founded in 2012 and maintains its corporate headquarters in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2021 |
|---|
| May 27, 2021 |
| -$0.03-21.71% vs estimate |
| $2.26M+5.11% vs estimate |
| Q3 2020 | Nov 30, 2020 | -$0.05-20.48% vs estimate | $1.45M-30.87% vs estimate |
|---|
| Q2 2020 | Aug 24, 2020 | -$0.04+28.28% vs estimate | $1.23M-11.72% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
$0.00$0.00 (0.0%)
EVIO, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Kaya Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.57% below the high.
$0.00$0.00 (0.0%)
Hemp, Inc’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00-$0.01 (-75.66%)
Planet Based Foods Global Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.72% below the high.
